Do you support this bill?

Assembly Bill A337

2021-2022 Legislative Session

Requires that for first opioid analgesic prescription of a calendar year the prescribing physician shall counsel the patient on the risks of overdose

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

2021-A337 (ACTIVE) - Details

Current Committee:
Assembly Health
Law Section:
Public Health Law
Laws Affected:
Add §3309-b, Pub Health L
Versions Introduced in Other Legislative Sessions:
2015-2016: A7812
2017-2018: A327
2019-2020: A672

2021-A337 (ACTIVE) - Summary

Requires that with the first prescription to a particular patient of an opioid of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice as defined by section four thousand two of this chapter, the prescribing physician shall counsel the patient on the risks of overdose, and inform the patient of the availability of an opioid antagonist, including, but not limited to, naloxone.

2021-A337 (ACTIVE) - Bill Text download pdf 

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                    337
 
                        2021-2022 Regular Sessions
 
                           I N  A S S E M B L Y
 
                                (PREFILED)
 
                              January 6, 2021
                                ___________
 
 Introduced  by  M.  of  A.  BRAUNSTEIN  -- read once and referred to the
   Committee on Health
 
 AN ACT to amend the public health law, in relation to  opioid  analgesic
   prescriptions
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. The public health law is amended by adding  a  new  section
 3309-b to read as follows:
   §   3309-B.   OPIOID   ANALGESIC   PRESCRIPTION.  1.  WITH  THE  FIRST
 PRESCRIPTION TO A PARTICULAR PATIENT OF AN OPIOID OF EACH YEAR  FOR  USE
 IN A SETTING OTHER THAN A GENERAL HOSPITAL OR NURSING HOME UNDER ARTICLE
 TWENTY-EIGHT OF THIS CHAPTER OR FACILITY UNDER ARTICLE THIRTY-ONE OF THE
 MENTAL  HYGIENE  LAW, OR WHEN A PRACTITIONER IS PRESCRIBING A CONTROLLED
 SUBSTANCE TO A PATIENT UNDER THE CARE OF HOSPICE AS DEFINED  BY  SECTION
 FOUR THOUSAND TWO OF THIS CHAPTER, THE PRESCRIBING PHYSICIAN SHALL COUN-
 SEL  THE PATIENT ON THE RISKS OF OVERDOSE, AND INFORM THE PATIENT OF THE
 AVAILABILITY OF AN OPIOID ANTAGONIST, INCLUDING,  BUT  NOT  LIMITED  TO,
 NALOXONE.
   2.  FOR  THE  PURPOSES OF THIS SECTION, THE FOLLOWING TERMS SHALL HAVE
 THE FOLLOWING MEANINGS:
   (A) "OPIOID ANALGESICS" MEANS THE MEDICINES  BUPRENORPHINE,  BUTORPHA-
 NOL,   CODEINE,  HYDROCODONE,  HYDROMORPHONE,  LEVORPHANOL,  MEPERIDINE,
 METHADONE, MORPHINE, NALBUPHINE,  OXYCODONE,  OXYMORPHONE,  PENTAZOCINE,
 PROPOXYPHENE AS WELL AS THEIR BRAND NAMES, ISOMERS AND COMBINATIONS.
   (B) "OPIOID ANTAGONIST" MEANS AN FDA-APPROVED DRUG THAT, WHEN ADMINIS-
 TERED,  NEGATES  OR  NEUTRALIZES IN WHOLE OR IN PART THE PHARMACOLOGICAL
 EFFECTS OF AN OPIOID IN THE BODY. THE OPIOID ANTAGONIST  IS  LIMITED  TO
 NALOXONE  OR  OTHER  MEDICATIONS  APPROVED  BY  THE  DEPARTMENT FOR THIS
 PURPOSE.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.